These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30779810)

  • 21. Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy.
    Muthigi A; Sidana A; George AK; Kongnyuy M; Maruf M; Valayil S; Wood BJ; Pinto PA
    Urol Oncol; 2017 Jan; 35(1):32.e1-32.e7. PubMed ID: 27743850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining the target prior to prostate fusion biopsy: the effect of MRI reporting on cancer detection.
    Westhoff N; Siegel F; Peter C; Hetjens S; Porubsky S; Martini T; von Hardenberg J; Michel MS; Budjan J; Ritter M
    World J Urol; 2019 Feb; 37(2):327-335. PubMed ID: 29967946
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of structured reporting in neuromuscular disorders.
    Alessandrino F; Cristiano L; Cinnante CM; Tartaglione T; Gerevini S; Verdolotti T; Colafati GS; Ghione E; Vitale R; Peverelli L; Brogna C; Berardinelli A; Moggio M; Mercuri EM; Pichiecchio A
    Radiol Med; 2019 Jul; 124(7):628-635. PubMed ID: 30852791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structured reporting in petrous bone MRI examinations: impact on report completeness and quality.
    Armbruster M; Gassenmaier S; Haack M; Reiter M; Nörenberg D; Henzler T; Sommer NN; Sommer WH; Braun F
    Int J Comput Assist Radiol Surg; 2018 Dec; 13(12):1971-1980. PubMed ID: 30039247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
    Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
    Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of a Structured Reporting Template on Adherence to Prostate Imaging Reporting and Data System Version 2 and on the Diagnostic Performance of Prostate MRI for Clinically Significant Prostate Cancer.
    Shaish H; Feltus W; Steinman J; Hecht E; Wenske S; Ahmed F
    J Am Coll Radiol; 2018 May; 15(5):749-754. PubMed ID: 29506919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PI-RADS classification: structured reporting for MRI of the prostate].
    Röthke M; Blondin D; Schlemmer HP; Franiel T
    Rofo; 2013 Mar; 185(3):253-61. PubMed ID: 23404430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer.
    Stabile A; Dell'Oglio P; De Cobelli F; Esposito A; Gandaglia G; Fossati N; Brembilla G; Cristel G; Cardone G; Deho' F; Losa A; Suardi N; Gaboardi F; Del Maschio A; Montorsi F; Briganti A
    Eur Urol Oncol; 2018 May; 1(1):29-36. PubMed ID: 31100225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difference in MRI-guided biopsy cancer detection rates between individual clinicians.
    Sathianathen NJ; Warlick CA; Soubra A; Balaji P; Metzger GJ; Spilseth B; Murugan P; Ordonez M; Weight CJ; Konety BR
    Urol Oncol; 2019 May; 37(5):299.e1-299.e6. PubMed ID: 30797649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic resonance imaging of the prostate: interpretation using the PI-RADS V2.
    Torregrosa Andrés A; Otero García M; Sineiro Galiñanes M
    Radiologia; 2017; 59(2):128-138. PubMed ID: 28012730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of structured reporting on developing head and neck ultrasound skills.
    Ernst BP; Katzer F; Künzel J; Hodeib M; Strieth S; Eckrich J; Tattermusch A; Froelich MF; Matthias C; Sommer WH; Becker S
    BMC Med Educ; 2019 Apr; 19(1):102. PubMed ID: 30971248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
    Moore CM; Kasivisvanathan V; Eggener S; Emberton M; Fütterer JJ; Gill IS; Grubb Iii RL; Hadaschik B; Klotz L; Margolis DJ; Marks LS; Melamed J; Oto A; Palmer SL; Pinto P; Puech P; Punwani S; Rosenkrantz AB; Schoots IG; Simon R; Taneja SS; Turkbey B; Ukimura O; van der Meulen J; Villers A; Watanabe Y;
    Eur Urol; 2013 Oct; 64(4):544-52. PubMed ID: 23537686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
    Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
    Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
    Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
    Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An initial negative round of targeted biopsies in men with highly suspicious multiparametric magnetic resonance findings does not exclude clinically significant prostate cancer-Preliminary experience.
    Costa DN; Kay FU; Pedrosa I; Kolski L; Lotan Y; Roehrborn CG; Hornberger B; Xi Y; Francis F; Rofsky NM
    Urol Oncol; 2017 Apr; 35(4):149.e15-149.e21. PubMed ID: 27939349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MRI-TRUS fusion biopsy of the prostate: Quality of image fusion in a clinical setting.
    Schlenker B; Apfelbeck M; Buchner A; Stief C; Clevert DA
    Clin Hemorheol Microcirc; 2018; 70(4):433-440. PubMed ID: 30347605
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnostic accuracy of a five-point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image-fusion targeted biopsy of the prostate.
    Shin T; Smyth TB; Ukimura O; Ahmadi N; de Castro Abreu AL; Ohe C; Oishi M; Mimata H; Gill IS
    BJU Int; 2018 Jan; 121(1):77-83. PubMed ID: 28749070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In patients with a previous negative prostate biopsy and a suspicious lesion on magnetic resonance imaging, is a 12-core biopsy still necessary in addition to a targeted biopsy?
    Salami SS; Ben-Levi E; Yaskiv O; Ryniker L; Turkbey B; Kavoussi LR; Villani R; Rastinehad AR
    BJU Int; 2015 Apr; 115(4):562-70. PubMed ID: 25252133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.